Kim Fejgin

1.0k total citations
27 papers, 736 citations indexed

About

Kim Fejgin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, Kim Fejgin has authored 27 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 5 papers in Social Psychology. Recurrent topics in Kim Fejgin's work include Neuroscience and Neuropharmacology Research (13 papers), Receptor Mechanisms and Signaling (12 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Kim Fejgin is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Receptor Mechanisms and Signaling (12 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Kim Fejgin collaborates with scholars based in Sweden, Denmark and United Kingdom. Kim Fejgin's co-authors include Erik Pålsson, Caroline Wass, Daniel Klamer, Lennart Svensson, Vibeke Nielsen, Jacob Nielsen, Thomas Werge, Jörgen A. Engel, Michael Didriksen and Trevor Archer and has published in prestigious journals such as Journal of Neuroscience, Biological Psychiatry and Cerebral Cortex.

In The Last Decade

Kim Fejgin

25 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim Fejgin Sweden	20	390	364	167	160	110	27	736
Gillian F. O’Meara United Kingdom	11	543 1.4×	834 2.3×	97 0.6×	218 1.4×	80 0.7×	11	1.1k
Rick Shin United States	13	255 0.7×	324 0.9×	112 0.7×	202 1.3×	44 0.4×	20	643
Brielle R. Ferguson United States	9	291 0.7×	547 1.5×	80 0.5×	403 2.5×	131 1.2×	9	956
Barbara Ziółkowska Poland	18	354 0.9×	496 1.4×	83 0.5×	117 0.7×	75 0.7×	34	821
Kerstin A. Ford United States	15	429 1.1×	782 2.1×	99 0.6×	223 1.4×	73 0.7×	15	1.0k
Sjoukje D. Kuipers Norway	9	249 0.6×	438 1.2×	65 0.4×	167 1.0×	54 0.5×	12	803
Liesl Duffy Australia	12	269 0.7×	397 1.1×	129 0.8×	49 0.3×	83 0.8×	13	697
Tyson Tragon United States	6	184 0.5×	253 0.7×	84 0.5×	80 0.5×	91 0.8×	10	548
Tara Teppen United States	16	395 1.0×	308 0.8×	78 0.5×	99 0.6×	36 0.3×	19	743
Е. М. Кондаурова Russia	15	181 0.5×	404 1.1×	59 0.4×	120 0.8×	70 0.6×	50	655

Countries citing papers authored by Kim Fejgin

Since Specialization

Citations

This map shows the geographic impact of Kim Fejgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Fejgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Fejgin more than expected).

Fields of papers citing papers by Kim Fejgin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Fejgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Fejgin. The network helps show where Kim Fejgin may publish in the future.

Co-authorship network of co-authors of Kim Fejgin

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Fejgin. A scholar is included among the top collaborators of Kim Fejgin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Fejgin. Kim Fejgin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wattiez, Anne‐Sophie, et al.. (2025). Pretreatment with an anti-CGRP monoclonal antibody attenuates mild TBI-induced tactile hypersensitivity in mice. The Journal of Headache and Pain. 26(1). 175–175.

Nielsen, Jacob, Kim Fejgin, Florence Sotty, et al.. (2017). A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission. Translational Psychiatry. 7(11). 1261–1261. 34 indexed citations

Qvist, Per, Jane Christensen, Irina Vardya, et al.. (2016). The Schizophrenia-Associated BRD1 Gene Regulates Behavior, Neurotransmission, and Expression of Schizophrenia Risk Enriched Gene Sets in Mice. Biological Psychiatry. 82(1). 62–76. 19 indexed citations

Nilsson, Simon, Pau Celada, Kim Fejgin, et al.. (2016). A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment. Psychopharmacology. 233(11). 2151–2163. 36 indexed citations

Didriksen, Michael, Kim Fejgin, Simon Nilsson, et al.. (2016). Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice. Journal of Psychiatry and Neuroscience. 42(1). 48–58. 57 indexed citations

Nilsson, Simon, Kim Fejgin, François Gastambide, et al.. (2016). Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome. Cerebral Cortex. 26(10). 3991–4003. 25 indexed citations

Kjærby, Celia, Christoffer Bundgaard, Kim Fejgin, Uffe Kristiansen, & Nils Ole Dalby. (2013). Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment. Neuropharmacology. 72. 157–168. 18 indexed citations

Fejgin, Kim, Jacob Nielsen, Michelle Rosgaard Birknow, et al.. (2013). A Mouse Model that Recapitulates Cardinal Features of the 15q13.3 Microdeletion Syndrome Including Schizophrenia- and Epilepsy-Related Alterations. Biological Psychiatry. 76(2). 128–137. 81 indexed citations

Wass, Caroline, Daniel Klamer, Erik Pålsson, et al.. (2011). L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study. BMC Medicine. 9(1). 40–40. 18 indexed citations

10.

Klamer, Daniel, Lennart Svensson, Kim Fejgin, & Erik Pålsson. (2010). Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing. European Neuropsychopharmacology. 21(3). 248–253. 7 indexed citations

11.

Broberg, Brian V., Bob Oranje, Birte Glenthøj, et al.. (2010). Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia—Gating of auditory-evoked potentials and prepulse inhibition. Behavioural Brain Research. 213(2). 142–147. 22 indexed citations

12.

Fejgin, Kim, et al.. (2009). Prefrontal GABAB Receptor Activation Attenuates Phencyclidine-Induced Impairments of Prepulse Inhibition: Involvement of Nitric Oxide. Neuropsychopharmacology. 34(7). 1673–1684. 28 indexed citations

13.

Wallén‐Mackenzie, Åsa, Karin Nordenankar, Kim Fejgin, et al.. (2009). Restricted Cortical and Amygdaloid Removal of Vesicular Glutamate Transporter 2 in Preadolescent Mice Impacts Dopaminergic Activity and Neuronal Circuitry of Higher Brain Function. Journal of Neuroscience. 29(7). 2238–2251. 49 indexed citations

14.

Wass, Caroline, Daniel Klamer, Kim Fejgin, & Erik Pålsson. (2009). The importance of nitric oxide in social dysfunction. Behavioural Brain Research. 200(1). 113–116. 19 indexed citations

15.

Wass, Caroline, Lennart Svensson, Kim Fejgin, et al.. (2008). Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility. Pharmacology Biochemistry and Behavior. 89(3). 352–359. 19 indexed citations

16.

Pålsson, Erik, Kim Fejgin, Caroline Wass, & Daniel Klamer. (2008). Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition. European Journal of Pharmacology. 590(1-3). 212–216. 27 indexed citations

17.

Fejgin, Kim, Erik Pålsson, Caroline Wass, et al.. (2007). The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology. 191(2). 377–385. 28 indexed citations

18.

Pålsson, Erik, Kim Fejgin, Caroline Wass, et al.. (2007). The amino acid l-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice. Psychopharmacology. 192(1). 9–15. 13 indexed citations

19.

Wass, Caroline, Trevor Archer, Erik Pålsson, et al.. (2006). Effects of phencyclidine on spatial learning and memory: Nitric oxide-dependent mechanisms. Behavioural Brain Research. 171(1). 147–153. 43 indexed citations

20.

Wass, Caroline, Trevor Archer, Erik Pålsson, et al.. (2006). Phencyclidine affects memory in a nitric oxide-dependent manner: Working and reference memory. Behavioural Brain Research. 174(1). 49–55. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact